Altimmune Reports Positive 48-Week Phase 2b Result...
Category : Clinical Trial Update 1 June 2026Altimmune has announced new 48-week results from its IMPACT Phase 2b trial evaluating pemvidutide, a...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
GSK and Ionis Report Positive Phase 3 Results for...
Category : Clinical Trial Update 1 June 2026New Hope for Patients Living with Chronic Hepatitis B Chronic hepatitis B (CHB) remains one of th...
MediciNova Completes Phase 2 Trial for MN-001 in N...
Category : Clinical Trial Update 27 May 2026MediciNova Reaches Important Clinical Milestone MediciNova has announced the completion of the la...
Jade Biosciences Doses First Patient in Phase 1 Tr...
Category : Clinical Trial Update 27 May 2026Jade Biosciences Starts Human Testing for JADE201 Jade Biosciences has announced that the first p...
A Single Infusion Drug That Might Lower Cholestero...
Category : Clinical Trial Update 26 May 2026Eli Lilly and Company shared new Phase 1b results for a drug called VERVE-102. The main idea is p...
Latest Newsletter Post
-
GSK and Ionis Report Positive Phase..
1 June 2026
-
Altimmune Reports Positive 48-Week..
1 June 2026
-
Jade Biosciences Doses First Patien..
27 May 2026
-
MediciNova Completes Phase 2 Trial..
27 May 2026
-
Ascletis Tweaks Its Oral GLP-1 Stra..
26 May 2026
